Cargando…
Clinical Utility of Rush Venom Immunotherapy: Current Status
Hymenoptera venom allergy (HVA) is the leading cause of anaphylactic reactions in adults and the second most common cause in children. Venom immunotherapy (VIT) is used to elicit an immune tolerance against hymenoptera venom in allergic patients and is based on the administration of purified venom e...
Autores principales: | Gruzelle, Vianney, Mailhol, Claire, Waters, David W, Guilleminault, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954838/ https://www.ncbi.nlm.nih.gov/pubmed/32021308 http://dx.doi.org/10.2147/JAA.S200917 |
Ejemplares similares
-
Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)
por: Stock, Richard, et al.
Publicado: (2020) -
Time-dependent cytokines changes in ultra-rush wasp venom immunotherapy
por: Urbańska, W., et al.
Publicado: (2023) -
Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush
por: Selcuk, Ali, et al.
Publicado: (2022) -
Safety of 100 µg venom immunotherapy rush protocols in children compared to adults
por: Stoevesandt, Johanna, et al.
Publicado: (2017) -
Stinging insect allergy: current perspectives on venom immunotherapy
por: Ludman, Sian W, et al.
Publicado: (2015)